nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2B6—Methimazole—Graves' disease	0.262	0.282	CbGbCtD
Perphenazine—CYP2C19—Methimazole—Graves' disease	0.166	0.179	CbGbCtD
Perphenazine—CYP1A2—Methimazole—Graves' disease	0.154	0.166	CbGbCtD
Perphenazine—CYP2C9—Methimazole—Graves' disease	0.138	0.149	CbGbCtD
Perphenazine—CYP2D6—Methimazole—Graves' disease	0.127	0.136	CbGbCtD
Perphenazine—CYP3A4—Methimazole—Graves' disease	0.0804	0.0868	CbGbCtD
Perphenazine—Liver injury—Propylthiouracil—Graves' disease	0.0021	0.128	CcSEcCtD
Perphenazine—AOX1—eye—Graves' disease	0.00144	0.0544	CbGeAlD
Perphenazine—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00136	0.0827	CcSEcCtD
Perphenazine—CALM3—eye—Graves' disease	0.00129	0.049	CbGeAlD
Perphenazine—Drowsiness—Methimazole—Graves' disease	0.00116	0.0707	CcSEcCtD
Perphenazine—Jaundice—Methimazole—Graves' disease	0.00114	0.0689	CcSEcCtD
Perphenazine—Agranulocytosis—Methimazole—Graves' disease	0.00109	0.066	CcSEcCtD
Perphenazine—AOX1—pituitary gland—Graves' disease	0.00107	0.0404	CbGeAlD
Perphenazine—AOX1—adipose tissue—Graves' disease	0.00106	0.0402	CbGeAlD
Perphenazine—CALM2—eye—Graves' disease	0.00102	0.0385	CbGeAlD
Perphenazine—CALM1—eye—Graves' disease	0.00101	0.0383	CbGeAlD
Perphenazine—Drowsiness—Propylthiouracil—Graves' disease	0.00099	0.0601	CcSEcCtD
Perphenazine—CALM2—connective tissue—Graves' disease	0.000978	0.0371	CbGeAlD
Perphenazine—CALM1—connective tissue—Graves' disease	0.000974	0.0369	CbGeAlD
Perphenazine—Jaundice—Propylthiouracil—Graves' disease	0.000965	0.0586	CcSEcCtD
Perphenazine—CALM3—pituitary gland—Graves' disease	0.00096	0.0364	CbGeAlD
Perphenazine—CALM3—adipose tissue—Graves' disease	0.000956	0.0362	CbGeAlD
Perphenazine—HTR7—connective tissue—Graves' disease	0.000951	0.036	CbGeAlD
Perphenazine—DRD2—eye—Graves' disease	0.000934	0.0354	CbGeAlD
Perphenazine—Agranulocytosis—Propylthiouracil—Graves' disease	0.000924	0.0561	CcSEcCtD
Perphenazine—AOX1—thyroid gland—Graves' disease	0.000919	0.0348	CbGeAlD
Perphenazine—CALM3—thyroid gland—Graves' disease	0.000827	0.0313	CbGeAlD
Perphenazine—Leukopenia—Methimazole—Graves' disease	0.000815	0.0495	CcSEcCtD
Perphenazine—CALM2—pituitary gland—Graves' disease	0.000754	0.0286	CbGeAlD
Perphenazine—CALM2—adipose tissue—Graves' disease	0.000751	0.0284	CbGeAlD
Perphenazine—CALM1—pituitary gland—Graves' disease	0.00075	0.0284	CbGeAlD
Perphenazine—CALM1—adipose tissue—Graves' disease	0.000747	0.0283	CbGeAlD
Perphenazine—HRH1—eye—Graves' disease	0.000737	0.0279	CbGeAlD
Perphenazine—HRH1—connective tissue—Graves' disease	0.00071	0.0269	CbGeAlD
Perphenazine—ADRA2A—connective tissue—Graves' disease	0.000698	0.0264	CbGeAlD
Perphenazine—DRD2—pituitary gland—Graves' disease	0.000693	0.0263	CbGeAlD
Perphenazine—Leukopenia—Propylthiouracil—Graves' disease	0.000693	0.0421	CcSEcCtD
Perphenazine—Somnolence—Methimazole—Graves' disease	0.00066	0.0401	CcSEcCtD
Perphenazine—CALM2—thyroid gland—Graves' disease	0.00065	0.0246	CbGeAlD
Perphenazine—CALM1—thyroid gland—Graves' disease	0.000647	0.0245	CbGeAlD
Perphenazine—CYP2C8—pituitary gland—Graves' disease	0.000625	0.0237	CbGeAlD
Perphenazine—HTR2A—eye—Graves' disease	0.000616	0.0233	CbGeAlD
Perphenazine—HTR2A—connective tissue—Graves' disease	0.000593	0.0225	CbGeAlD
Perphenazine—Urticaria—Methimazole—Graves' disease	0.00059	0.0358	CcSEcCtD
Perphenazine—Body temperature increased—Methimazole—Graves' disease	0.000587	0.0356	CcSEcCtD
Perphenazine—Somnolence—Propylthiouracil—Graves' disease	0.000561	0.0341	CcSEcCtD
Perphenazine—HRH1—adipose tissue—Graves' disease	0.000545	0.0207	CbGeAlD
Perphenazine—ADRA2A—pituitary gland—Graves' disease	0.000537	0.0204	CbGeAlD
Perphenazine—ADRA2A—adipose tissue—Graves' disease	0.000535	0.0203	CbGeAlD
Perphenazine—Pruritus—Methimazole—Graves' disease	0.000525	0.0319	CcSEcCtD
Perphenazine—CYP1A2—thyroid gland—Graves' disease	0.000504	0.0191	CbGeAlD
Perphenazine—Urticaria—Propylthiouracil—Graves' disease	0.000502	0.0305	CcSEcCtD
Perphenazine—Body temperature increased—Propylthiouracil—Graves' disease	0.000499	0.0303	CcSEcCtD
Perphenazine—Headache—Methimazole—Graves' disease	0.000465	0.0282	CcSEcCtD
Perphenazine—ADRA2A—thyroid gland—Graves' disease	0.000463	0.0176	CbGeAlD
Perphenazine—HTR2A—pituitary gland—Graves' disease	0.000457	0.0173	CbGeAlD
Perphenazine—Pruritus—Propylthiouracil—Graves' disease	0.000447	0.0271	CcSEcCtD
Perphenazine—Headache—Propylthiouracil—Graves' disease	0.000396	0.024	CcSEcCtD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.04e-05	0.00201	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—TSHR—Graves' disease	5.8e-05	0.00193	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—TSHR—Graves' disease	5.79e-05	0.00193	CbGpPWpGaD
Perphenazine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	5.77e-05	0.00192	CbGpPWpGaD
Perphenazine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	5.63e-05	0.00188	CbGpPWpGaD
Perphenazine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	5.58e-05	0.00186	CbGpPWpGaD
Perphenazine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	5.58e-05	0.00186	CbGpPWpGaD
Perphenazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	5.58e-05	0.00186	CbGpPWpGaD
Perphenazine—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.57e-05	0.00186	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	5.5e-05	0.00183	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—TSHR—Graves' disease	5.5e-05	0.00183	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—B3GNT2—Graves' disease	5.48e-05	0.00183	CbGpPWpGaD
Perphenazine—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	5.4e-05	0.0018	CbGpPWpGaD
Perphenazine—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	5.38e-05	0.00179	CbGpPWpGaD
Perphenazine—CALM3—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	5.14e-05	0.00171	CbGpPWpGaD
Perphenazine—CALM3—Alzheimers Disease—TNF—Graves' disease	5e-05	0.00167	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—TSHR—Graves' disease	4.99e-05	0.00166	CbGpPWpGaD
Perphenazine—CALM1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	4.97e-05	0.00166	CbGpPWpGaD
Perphenazine—CALM2—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	4.97e-05	0.00166	CbGpPWpGaD
Perphenazine—CALM1—Alzheimers Disease—TNF—Graves' disease	4.83e-05	0.00161	CbGpPWpGaD
Perphenazine—CALM2—Alzheimers Disease—TNF—Graves' disease	4.83e-05	0.00161	CbGpPWpGaD
Perphenazine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	4.81e-05	0.0016	CbGpPWpGaD
Perphenazine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	4.74e-05	0.00158	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	4.73e-05	0.00158	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.7e-05	0.00157	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	4.7e-05	0.00157	CbGpPWpGaD
Perphenazine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	4.67e-05	0.00156	CbGpPWpGaD
Perphenazine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	4.66e-05	0.00155	CbGpPWpGaD
Perphenazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	4.66e-05	0.00155	CbGpPWpGaD
Perphenazine—HRH1—GPCR ligand binding—CXCL10—Graves' disease	4.66e-05	0.00155	CbGpPWpGaD
Perphenazine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	4.6e-05	0.00153	CbGpPWpGaD
Perphenazine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	4.6e-05	0.00153	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—IFIH1—Graves' disease	4.54e-05	0.00151	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—IFIH1—Graves' disease	4.39e-05	0.00146	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—IFIH1—Graves' disease	4.39e-05	0.00146	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	4.29e-05	0.00143	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	4.27e-05	0.00142	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	4.25e-05	0.00142	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	4.15e-05	0.00138	CbGpPWpGaD
Perphenazine—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	4.13e-05	0.00138	CbGpPWpGaD
Perphenazine—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	4.12e-05	0.00137	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	4.08e-05	0.00136	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—TSHR—Graves' disease	4.07e-05	0.00136	CbGpPWpGaD
Perphenazine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	4.04e-05	0.00135	CbGpPWpGaD
Perphenazine—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	4.02e-05	0.00134	CbGpPWpGaD
Perphenazine—AOX1—Disease—HLA-A—Graves' disease	3.92e-05	0.00131	CbGpPWpGaD
Perphenazine—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	3.88e-05	0.00129	CbGpPWpGaD
Perphenazine—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	3.88e-05	0.00129	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—GC—Graves' disease	3.79e-05	0.00126	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—TSHR—Graves' disease	3.77e-05	0.00126	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—CXCL10—Graves' disease	3.75e-05	0.00125	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—CXCL10—Graves' disease	3.74e-05	0.00125	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	3.71e-05	0.00124	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	3.71e-05	0.00124	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—TSHR—Graves' disease	3.7e-05	0.00123	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HLA-E—Graves' disease	3.57e-05	0.00119	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—GC—Graves' disease	3.56e-05	0.00119	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	3.55e-05	0.00118	CbGpPWpGaD
Perphenazine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	3.49e-05	0.00116	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—GC—Graves' disease	3.46e-05	0.00115	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HLA-E—Graves' disease	3.45e-05	0.00115	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HLA-E—Graves' disease	3.45e-05	0.00115	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-E—Graves' disease	3.43e-05	0.00114	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TSHR—Graves' disease	3.42e-05	0.00114	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TSHR—Graves' disease	3.42e-05	0.00114	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	3.37e-05	0.00112	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CD40—Graves' disease	3.35e-05	0.00112	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—GC—Graves' disease	3.35e-05	0.00112	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—GC—Graves' disease	3.35e-05	0.00112	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-E—Graves' disease	3.32e-05	0.00111	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-E—Graves' disease	3.32e-05	0.00111	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CTLA4—Graves' disease	3.3e-05	0.0011	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CD40—Graves' disease	3.24e-05	0.00108	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CD40—Graves' disease	3.24e-05	0.00108	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—CXCL10—Graves' disease	3.22e-05	0.00107	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CTLA4—Graves' disease	3.2e-05	0.00107	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CTLA4—Graves' disease	3.2e-05	0.00107	CbGpPWpGaD
Perphenazine—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	3.15e-05	0.00105	CbGpPWpGaD
Perphenazine—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	3.15e-05	0.00105	CbGpPWpGaD
Perphenazine—CALM3—Disease—B3GNT2—Graves' disease	3.13e-05	0.00104	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—TSHR—Graves' disease	3.08e-05	0.00103	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	3.05e-05	0.00102	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	3.04e-05	0.00101	CbGpPWpGaD
Perphenazine—CALM2—Disease—B3GNT2—Graves' disease	3.03e-05	0.00101	CbGpPWpGaD
Perphenazine—CALM1—Disease—B3GNT2—Graves' disease	3.03e-05	0.00101	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—GC—Graves' disease	3.01e-05	0.001	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—TSHR—Graves' disease	2.98e-05	0.000992	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—TSHR—Graves' disease	2.98e-05	0.000992	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TSHR—Graves' disease	2.95e-05	0.000983	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—IL2RA—Graves' disease	2.9e-05	0.000968	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—B3GNT2—Graves' disease	2.88e-05	0.000959	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—IL2RA—Graves' disease	2.86e-05	0.000954	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—IL2RA—Graves' disease	2.86e-05	0.000953	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	2.77e-05	0.000924	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	2.76e-05	0.00092	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-DQB1—Graves' disease	2.72e-05	0.000907	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	2.71e-05	0.000905	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—B3GNT2—Graves' disease	2.7e-05	0.000899	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—GC—Graves' disease	2.69e-05	0.000896	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	2.68e-05	0.000894	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—IL2RA—Graves' disease	2.65e-05	0.000883	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IFIH1—Graves' disease	2.64e-05	0.000881	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	2.64e-05	0.000879	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	2.63e-05	0.000878	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-DQB1—Graves' disease	2.63e-05	0.000877	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-DQB1—Graves' disease	2.63e-05	0.000877	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—B3GNT2—Graves' disease	2.62e-05	0.000875	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—IL2RA—Graves' disease	2.56e-05	0.000854	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—IL2RA—Graves' disease	2.56e-05	0.000854	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IFIH1—Graves' disease	2.56e-05	0.000853	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IFIH1—Graves' disease	2.56e-05	0.000853	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—HLA-B—Graves' disease	2.54e-05	0.000848	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CD8A—Graves' disease	2.54e-05	0.000847	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—B3GNT2—Graves' disease	2.54e-05	0.000846	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—B3GNT2—Graves' disease	2.54e-05	0.000846	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TSHR—Graves' disease	2.53e-05	0.000845	CbGpPWpGaD
Perphenazine—AOX1—Disease—CD4—Graves' disease	2.53e-05	0.000843	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TSHR—Graves' disease	2.52e-05	0.000841	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—GC—Graves' disease	2.47e-05	0.000824	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—IL2RA—Graves' disease	2.46e-05	0.000822	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—HLA-B—Graves' disease	2.46e-05	0.000821	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—HLA-B—Graves' disease	2.46e-05	0.000821	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CD8A—Graves' disease	2.46e-05	0.000819	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CD8A—Graves' disease	2.46e-05	0.000819	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—GC—Graves' disease	2.45e-05	0.000817	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-B—Graves' disease	2.44e-05	0.000815	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	2.43e-05	0.000812	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	2.4e-05	0.0008	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	2.4e-05	0.000799	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CXCL10—Graves' disease	2.39e-05	0.000797	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-B—Graves' disease	2.36e-05	0.000788	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-B—Graves' disease	2.36e-05	0.000788	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	2.33e-05	0.000778	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	2.32e-05	0.000774	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—B3GNT2—Graves' disease	2.28e-05	0.000761	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-A—Graves' disease	2.26e-05	0.000755	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TSHR—Graves' disease	2.23e-05	0.000742	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CXCL10—Graves' disease	2.21e-05	0.000738	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CXCL10—Graves' disease	2.21e-05	0.000737	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-A—Graves' disease	2.19e-05	0.00073	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-A—Graves' disease	2.19e-05	0.00073	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TSHR—Graves' disease	2.19e-05	0.00073	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TSHR—Graves' disease	2.19e-05	0.000728	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	2.18e-05	0.000727	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	2.12e-05	0.000707	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	2.11e-05	0.000703	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GC—Graves' disease	2.09e-05	0.000698	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-E—Graves' disease	2.08e-05	0.000693	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-DRB1—Graves' disease	2.07e-05	0.00069	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	2.05e-05	0.000683	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—B3GNT2—Graves' disease	2.04e-05	0.000679	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD40—Graves' disease	2.03e-05	0.000678	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	2.02e-05	0.000672	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-E—Graves' disease	2.01e-05	0.000671	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-E—Graves' disease	2.01e-05	0.000671	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	2.01e-05	0.000671	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CTLA4—Graves' disease	2e-05	0.000668	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-DRB1—Graves' disease	2e-05	0.000667	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-DRB1—Graves' disease	2e-05	0.000667	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	1.99e-05	0.000664	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CXCL10—Graves' disease	1.99e-05	0.000663	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—ICAM1—Graves' disease	1.99e-05	0.000662	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD40—Graves' disease	1.97e-05	0.000656	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD40—Graves' disease	1.97e-05	0.000656	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CTLA4—Graves' disease	1.94e-05	0.000646	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CTLA4—Graves' disease	1.94e-05	0.000646	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CXCL10—Graves' disease	1.92e-05	0.000641	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CXCL10—Graves' disease	1.92e-05	0.000641	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—ICAM1—Graves' disease	1.92e-05	0.00064	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—ICAM1—Graves' disease	1.92e-05	0.00064	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CXCL10—Graves' disease	1.9e-05	0.000635	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—B3GNT2—Graves' disease	1.87e-05	0.000625	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	1.86e-05	0.00062	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—B3GNT2—Graves' disease	1.86e-05	0.000619	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	1.83e-05	0.000612	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	1.83e-05	0.00061	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL2RA—Graves' disease	1.83e-05	0.000609	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TSHR—Graves' disease	1.82e-05	0.000606	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TSHR—Graves' disease	1.76e-05	0.000586	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TSHR—Graves' disease	1.76e-05	0.000586	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL2RA—Graves' disease	1.69e-05	0.000564	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL2RA—Graves' disease	1.69e-05	0.000563	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	1.67e-05	0.000555	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-DQB1—Graves' disease	1.65e-05	0.00055	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	1.64e-05	0.000546	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	1.63e-05	0.000543	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GC—Graves' disease	1.62e-05	0.000539	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-DQB1—Graves' disease	1.6e-05	0.000532	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-DQB1—Graves' disease	1.6e-05	0.000532	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—B3GNT2—Graves' disease	1.59e-05	0.000529	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD8A—Graves' disease	1.54e-05	0.000514	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL2RA—Graves' disease	1.52e-05	0.000507	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—CD4—Graves' disease	1.52e-05	0.000506	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD8A—Graves' disease	1.49e-05	0.000497	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD8A—Graves' disease	1.49e-05	0.000497	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-B—Graves' disease	1.48e-05	0.000494	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL2RA—Graves' disease	1.47e-05	0.00049	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL2RA—Graves' disease	1.47e-05	0.00049	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—CD4—Graves' disease	1.47e-05	0.00049	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—CD4—Graves' disease	1.47e-05	0.00049	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CD4—Graves' disease	1.46e-05	0.000486	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL2RA—Graves' disease	1.46e-05	0.000485	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL10—Graves' disease	1.44e-05	0.000479	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-B—Graves' disease	1.43e-05	0.000478	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-B—Graves' disease	1.43e-05	0.000478	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	1.42e-05	0.000472	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL10—Graves' disease	1.41e-05	0.000471	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CD4—Graves' disease	1.41e-05	0.00047	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CD4—Graves' disease	1.41e-05	0.00047	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL2RA—Graves' disease	1.39e-05	0.000463	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-A—Graves' disease	1.37e-05	0.000458	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL2RA—Graves' disease	1.34e-05	0.000448	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL2RA—Graves' disease	1.34e-05	0.000448	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-A—Graves' disease	1.33e-05	0.000443	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-A—Graves' disease	1.33e-05	0.000443	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	1.29e-05	0.000429	CbGpPWpGaD
Perphenazine—CALM3—Disease—HLA-A—Graves' disease	1.27e-05	0.000423	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-DRB1—Graves' disease	1.25e-05	0.000418	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	1.25e-05	0.000417	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	1.25e-05	0.000415	CbGpPWpGaD
Perphenazine—CALM2—Disease—HLA-A—Graves' disease	1.23e-05	0.000409	CbGpPWpGaD
Perphenazine—CALM1—Disease—HLA-A—Graves' disease	1.23e-05	0.000409	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.23e-05	0.000408	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-DRB1—Graves' disease	1.21e-05	0.000405	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-DRB1—Graves' disease	1.21e-05	0.000405	CbGpPWpGaD
Perphenazine—CALM3—Immune System—ICAM1—Graves' disease	1.2e-05	0.000401	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL10—Graves' disease	1.17e-05	0.000392	CbGpPWpGaD
Perphenazine—CALM2—Immune System—ICAM1—Graves' disease	1.16e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM1—Immune System—ICAM1—Graves' disease	1.16e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL10—Graves' disease	1.14e-05	0.000379	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL10—Graves' disease	1.14e-05	0.000379	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL2RA—Graves' disease	1.1e-05	0.000366	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	1.08e-05	0.000361	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL2RA—Graves' disease	1.08e-05	0.00036	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	9.84e-06	0.000328	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IFNG—Graves' disease	9.16e-06	0.000305	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2RA—Graves' disease	8.98e-06	0.000299	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IFNG—Graves' disease	8.86e-06	0.000295	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IFNG—Graves' disease	8.86e-06	0.000295	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD4—Graves' disease	8.85e-06	0.000295	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2RA—Graves' disease	8.69e-06	0.00029	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2RA—Graves' disease	8.69e-06	0.00029	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD4—Graves' disease	8.56e-06	0.000285	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD4—Graves' disease	8.56e-06	0.000285	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1B—Graves' disease	8.17e-06	0.000272	CbGpPWpGaD
Perphenazine—CALM3—Disease—CD4—Graves' disease	8.17e-06	0.000272	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1B—Graves' disease	7.91e-06	0.000264	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1B—Graves' disease	7.91e-06	0.000264	CbGpPWpGaD
Perphenazine—CALM2—Disease—CD4—Graves' disease	7.9e-06	0.000263	CbGpPWpGaD
Perphenazine—CALM1—Disease—CD4—Graves' disease	7.9e-06	0.000263	CbGpPWpGaD
